Human transferrin for the treatment of anemia of chronic disease (ACD) and of functional iron deficiency

Details for Australian Patent Application No. 2003203505 (hide)

International Classifications

Event Publications

1 May 2003 Complete Application Filed

Priority application(s): 102 15 315.9 05.04.02 DE

23 October 2003 Application Open to Public Inspection

Published as AU-B-2003203505

17 March 2005 Change of Name(s) of Applicant(s), Section 104

Aventis Behring GmbH The name of the applicant has been changed to ZLB Behring GmbH

23 August 2007 Change of Name(s) of Applicant(s), Section 104

ZLB Behring GmbH The name of the applicant has been changed to CSL Behring GmbH

12 June 2008 Assignment before Grant

CSL Behring GmbH The application has been assigned to DrugConsult.Net Dr. Schlichthaar und Partner Arzte und Wissenschaftler

23 October 2008 Application Accepted

Published as AU-B-2003203505

19 February 2009 Standard Patent Sealed

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.